Galapagos NV
GLPG
#4563
Rank
HK$16.44 B
Marketcap
HK$245.92
Share price
-0.57%
Change (1 day)
17.26%
Change (1 year)

Galapagos NV (GLPG) - Cash on Hand

Cash on Hand as of September 2025 : HK$27.86 Billion

According to Galapagos NV's latest financial reports the company has HK$27.86 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Galapagos NV - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$25.18 B-20.82%
2023-12-31HK$31.81 B-7.29%
2022-12-31HK$34.31 B-17.38%
2021-12-31HK$41.53 B-15.61%
2020-12-31HK$49.21 B-2.42%
2019-12-31HK$50.43 B336.15%
2018-12-31HK$11.56 B7.15%
2017-12-31HK$10.79 B35.95%
2016-12-31HK$7.93 B175.25%
2015-12-31HK$2.88 B62.87%
2014-12-31HK$1.77 B19.67%
2013-12-31HK$1.47 B52.48%
2012-12-31HK$0.97 B195.53%
2011-12-31HK$0.32 B-21.47%
2010-12-31HK$0.41 B-20.57%
2009-12-31HK$0.52 B78.4%
2008-12-31HK$0.29 B-47.42%
2007-12-31HK$0.56 B6.14%
2006-12-31HK$0.52 B143.74%
2005-12-31HK$0.21 B100.28%
2004-12-31HK$0.10 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
AstraZeneca
AZN
HK$63.69 B 128.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
HK$144.49 B 418.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$81.36 B 191.99%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
HK$44.14 B 58.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
HK$0.57 B-97.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$60.19 B 116.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$17.14 B-38.46%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
HK$34.59 B 24.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
HK$141.78 B 408.83%๐Ÿ‡บ๐Ÿ‡ธ USA